MADISON, Wis.--(BUSINESS WIRE)--CB Insights today named Redox to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world. CB Insights CEO Anand Sanwal revealed the final Digital Health 150 during Future of Health, a gathering of top executives across some of the largest healthcare institutions, startups, and investment firms. Redox Co-founder and President Niko Skievaski will be presenting at the conference on October 3 at 11 a.m.
“We are delighted to be positioned among the top innovative digital health companies worldwide, right on the heels of our recognition in the Modern Healthcare Best Places to Work,” said Luke Bonney, CEO, Redox. “These honors are further testament to the invaluable work Redox is doing to simplify the way healthcare organizations exchange data, which, in turn, accelerates the development and deployment of new technology across those organizations. Redox standardizes healthcare data with a vendor-agnostic application programming interface (API), single point of integration and network approach that drives value for software developers and healthcare organizations. This strategy has been validated by our recent $33 million Series C funding round led by global investment firm Battery Ventures with participation from existing investors .406 Ventures, RRE Ventures and Intermountain Ventures.”
A rapidly growing list of over 500 healthcare delivery organizations and hundreds of digital health vendors use the Redox Platform to easily exchange information with partners. Among the hundreds of high-profile healthcare organizations and technology vendors working with Redox are AdventHealth, Atrium Health, Brigham & Women’s Hospital, Clarify Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, NowPow, Ochsner, OSF HealthCare, PointClickCare, ResMed, Stryker, University of Pennsylvania, and WellStar.
“From pharmaceuticals to patient care, technology is rapidly changing healthcare, and the Digital Health 150 showcases the 150 best startups spearheading innovation and change in the sector,” said Sanwal. “It’s a privilege to use CB Insights’ data to identify and shine a light on these companies, and we look forward to tracking their success in 2019 and beyond.”
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors, including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum. The Digital Health 150 companies span the globe, located in Canada, China, Germany, Israel, the United States, and the United Kingdom, and are supported by more than 360 investors.
About CB Insights
At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes, and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange healthcare data. With just one connection, data can be transmitted across a growing network of more than 500 healthcare delivery organizations and 236 independent software vendors. Members of the Redox Network exchange more than seven million patient records per day, leveraging a single data standard compatible with more than 40 electronic health record systems. Learn how you can leverage the Redox Platform at www.redoxengine.com. Please follow us on Twitter and LinkedIn.